dr. bestvina on the keynote-407 trial in squamous nsclc
Published 4 years ago • 248 plays • Length 0:54Download video MP4
Download video MP3
Similar videos
-
4:52
the keynote-407 trial in metastatic squamous nsclc
-
1:00
dr. raez on the keynote-407 trial in squamous cell carcinoma of the lung
-
3:29
squamous cell frontline therapy: impower 131, keynote-407
-
2:53
keynote-407: pembrolizumab plus chemo improves os and pfs in nsclc
-
9:33
keynote-407: practice-changing positive trial for advanced squamous nsclc (bmic-039)
-
4:23
keynote-407: 3-year follow-up of pembrolizumab plus chemo in nsclc
-
5:42
role of i/o with chemotherapy in advanced squamous nsclc
-
3:23
treatment options for relapsed squamous cell lung cancer
-
1:00
dr. kris on the impact of bevacizumab biosimilars in lung cancer
-
1:55
dr. rodriguez-abreu on the final analysis of the keynote-189 trial in nsclc
-
1:09
dr. herbst on the bevacizumab biosimilar in lung cancer
-
0:59
dr. rodriguez-abreu on updated results from the keynote-189 trial in nsclc
-
3:04
keynote-024 update: pembrolizumab vs platinum-based chemotherapy in nsclc
-
12:26
asco 2018 - potential showdown of two positive trials? keynote 407 and impower 131
-
1:13
keynote-b84: pepinemab pembrolizumab for metastatic/recurrent head & neck squamous cell carcinoma
-
1:06
improving outcomes for patients with metastatic nsclc with immunotherapy
-
53:49
the role of immunotherapy in late stage nsclc webinar
-
3:03
keynote-799: pembro chemoradiotherapy in locally advanced nsclc
-
4:03
keynote-040: groundbreaking results for pembrolizumab in head and neck cancer